DRI HEALTHCARE TRUST (DHT-UN.CA) Stock Overview
Canada - TSX:DHT-UN - CA23344H1091
14.46 CAD
0 (0%)
Overall DHT-UN gets a fundamental rating of 5 out of 10. We evaluated DHT-UN against 32 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of DHT-UN get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on DHT-UN.
1. Profitability
1.1 Basic Checks
In the past year DHT-UN was profitable.
DHT-UN had a positive operating cash flow in the past year.
1.2 Ratios
DHT-UN's Return On Assets of 0.41% is fine compared to the rest of the industry. DHT-UN outperforms 75.00% of its industry peers.
The Return On Equity of DHT-UN (0.78%) is better than 71.88% of its industry peers.
DHT-UN has a better Return On Invested Capital (3.82%) than 68.75% of its industry peers.
DHT-UN had an Average Return On Invested Capital over the past 3 years of 1.94%. This is significantly below the industry average of 7.94%.
The 3 year average ROIC (1.94%) for DHT-UN is below the current ROIC(3.82%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.41% | ||
| ROE | 0.78% | ||
| ROIC | 3.82% |
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of DHT-UN (2.11%) is better than 78.13% of its industry peers.
Looking at the Operating Margin, with a value of 25.45%, DHT-UN belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
DHT-UN's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.45% | ||
| PM (TTM) | 2.11% | ||
| GM | N/A |
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
DHT-UN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DHT-UN remains at a similar level compared to 1 year ago.
The debt/assets ratio for DHT-UN is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.41, we must say that DHT-UN is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.41, DHT-UN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
DHT-UN has a debt to FCF ratio of 3.05. This is a good value and a sign of high solvency as DHT-UN would need 3.05 years to pay back of all of its debts.
DHT-UN has a Debt to FCF ratio of 3.05. This is amongst the best in the industry. DHT-UN outperforms 90.63% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that DHT-UN is somewhat dependend on debt financing.
The Debt to Equity ratio of DHT-UN (0.77) is worse than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.05 | ||
| Altman-Z | 1.41 |
ROIC/WACC0.5
WACC7.64%
2.3 Liquidity
DHT-UN has a Current Ratio of 1.83. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.83, DHT-UN is in line with its industry, outperforming 53.13% of the companies in the same industry.
DHT-UN has a Quick Ratio of 1.83. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
DHT-UN has a better Quick ratio (1.83) than 78.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
DHT-UN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.89%.
DHT-UN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.09% yearly.
DHT-UN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.24%.
The Revenue has been growing by 32.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.89%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%4.08%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%6.07%
3.2 Future
The Earnings Per Share is expected to grow by 10.64% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.41% on average over the next years. This is quite good.
EPS Next Y-4.59%
EPS Next 2Y3.65%
EPS Next 3Y6.08%
EPS Next 5Y10.64%
Revenue Next Year10.56%
Revenue Next 2Y5.58%
Revenue Next 3Y3.77%
Revenue Next 5Y9.41%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 6.73 indicates a rather cheap valuation of DHT-UN.
Based on the Price/Earnings ratio, DHT-UN is valued cheaper than 93.75% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.53, DHT-UN is valued rather cheaply.
DHT-UN is valuated cheaply with a Price/Forward Earnings ratio of 6.20.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DHT-UN indicates a rather cheap valuation: DHT-UN is cheaper than 93.75% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DHT-UN to the average of the S&P500 Index (23.04), we can say DHT-UN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.73 | ||
| Fwd PE | 6.2 |
4.2 Price Multiples
87.50% of the companies in the same industry are more expensive than DHT-UN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DHT-UN is valued cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.46 | ||
| EV/EBITDA | 7.79 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.65%
EPS Next 3Y6.08%
5. Dividend
5.1 Amount
DHT-UN has a Yearly Dividend Yield of 4.57%, which is a nice return.
DHT-UN's Dividend Yield is rather good when compared to the industry average which is at 3.12. DHT-UN pays more dividend than 100.00% of the companies in the same industry.
DHT-UN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.57% |
5.2 History
DHT-UN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y3.65%
EPS Next 3Y6.08%
TSX:DHT-UN (10/15/2025, 7:00:00 PM)
14.46
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.4%
Inst Owner ChangeN/A
Ins Owners0.89%
Ins Owner ChangeN/A
Market Cap798.05M
Analysts80
Price Target19.12 (32.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.57% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.16%
Min EPS beat(2)-21.52%
Max EPS beat(2)5.2%
EPS beat(4)3
Avg EPS beat(4)6.36%
Min EPS beat(4)-21.52%
Max EPS beat(4)39.35%
EPS beat(8)5
Avg EPS beat(8)18.78%
EPS beat(12)7
Avg EPS beat(12)90.93%
EPS beat(16)8
Avg EPS beat(16)66.47%
Revenue beat(2)0
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)-0.37%
Revenue beat(4)2
Avg Revenue beat(4)14.3%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)46.19%
Revenue beat(8)5
Avg Revenue beat(8)27.34%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.44%
PT rev (3m)-6.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.84%
EPS NY rev (1m)3.74%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.73 | ||
| Fwd PE | 6.2 | ||
| P/S | 4.27 | ||
| P/FCF | 5.46 | ||
| P/OCF | 5.46 | ||
| P/B | 1.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.79 |
EPS(TTM)2.15
EY14.87%
EPS(NY)2.33
Fwd EY16.12%
FCF(TTM)2.65
FCFY18.32%
OCF(TTM)2.65
OCFY18.32%
SpS3.38
BVpS9.12
TBVpS-4.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.41% | ||
| ROE | 0.78% | ||
| ROCE | 5.31% | ||
| ROIC | 3.82% | ||
| ROICexc | 4.21% | ||
| ROICexgc | 90.74% | ||
| OM | 25.45% | ||
| PM (TTM) | 2.11% | ||
| GM | N/A | ||
| FCFM | 78.26% |
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)2.05%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.74%
ROCE(5y)N/A
ROICexcg growth 3Y44.9%
ROICexcg growth 5YN/A
ROICexc growth 3Y-7.25%
ROICexc growth 5YN/A
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.05 | ||
| Debt/EBITDA | 2.61 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.99% | ||
| Profit Quality | 3716.37% | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 1.41 |
F-Score6
WACC7.64%
ROIC/WACC0.5
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.89%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%4.08%
EPS Next Y-4.59%
EPS Next 2Y3.65%
EPS Next 3Y6.08%
EPS Next 5Y10.64%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%6.07%
Revenue Next Year10.56%
Revenue Next 2Y5.58%
Revenue Next 3Y3.77%
Revenue Next 5Y9.41%
EBIT growth 1Y343.32%
EBIT growth 3Y24.15%
EBIT growth 5YN/A
EBIT Next Year104.78%
EBIT Next 3Y26.53%
EBIT Next 5Y23.58%
FCF growth 1Y103.46%
FCF growth 3Y19.16%
FCF growth 5YN/A
OCF growth 1Y103.46%
OCF growth 3Y19.16%
OCF growth 5YN/A